Stimulus-Secretion Coupling in Diseased Lacrimal Gland

患病泪腺中的刺激-分泌耦合

基本信息

  • 批准号:
    7584767
  • 负责人:
  • 金额:
    $ 50万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Inflammatory diseases of the lacrimal gland such as Sjvgren's syndrome, sarcoidosis, and chronic graft versus-host disease or simply as occurs with advanced age, lead to inadequate secretion of the aqueous layer of the tear film, which is a leading cause of keratoconjunctivitis sicca (KCS) or dry eye syndromes. The hallmarks of lacrimal gland inflammation are the presence of leukocytic infiltrates, loss of acinar epithelial cells (the secreting cells), and increased production of proinflammatory cytokines. Lacrimal gland epithelial cells are terminally differentiated and hence are believed to be unable to proliferate. We discovered that murine lacrimal gland epithelial cells can proliferate in response to tissue insult. The overall goal of this application is to decipher the mechanisms that govern murine lacrimal gland regeneration following experimentally induced inflammation. The knowledge gained will unravel new strategies to promote regeneration of inflamed human lacrimal glands that would restore adequate aqueous tear production. Based on our preliminary data and reports in the literature, we hypothesize that experimentally induced inflammation of the lacrimal gland triggers acinar cell apoptosis that subsequently induces acinar cell differentiation from ductal cells or ductal cell-associated stem/progenitor cells with ensuing proliferation mediated by the increased production of fibroblast growth factor 10 (FGFI 0) and/or bone morphogenetic protein 7 (BMP7). We propose three specific aims: 1 -Determine if lacrimal gland epithelial cells are lost by apoptosis or necrosis during experimentally induced inflammation; 2-Determine which cells are responsible for the regeneration of the murine lacrimal gland following experimentally induced inflammation; and 3- Determine which effector molecules are responsible for triggering lacrimal gland repair following experimentally induced inflammation and investigate if these factors could trigger/accelerate lacrimal gland repair in disease states. There are currently no cures for severe dry eye resulting from loss of the moisture producing cells of the lacrimal glands. The studies described here, if successful, will lead to new strategies to halt, and maybe reverse, the loss of these cells which will restore normal tear production and alleviate the ocular surface discomfort associated with dry eye syndromes. PUBLIC HEALTH RELEVANCE There are currently no cures for severe dry eye resulting from loss of the moisture producing cells of the lacrimal glands. We discovered that murine lacrimal gland epithelial cells can proliferate in response to tissue insult. The overall goal of this application is to decipher the mechanisms that govern murine lacrimal gland regeneration following experimentally induced inflammation. The knowledge gained will unravel new strategies to promote regeneration of inflamed human lacrimal glands that would restore adequate aqueous tear production.
描述(由申请人提供):泪腺的炎性疾病,如干燥综合征、结节病和慢性移植物抗宿主病,或仅发生于高龄,导致泪膜水层分泌不足,这是干燥性角结膜炎(KCS)或干眼综合征的主要原因。泪腺炎症的标志是存在白细胞浸润、腺泡上皮细胞(分泌细胞)损失和促炎细胞因子产生增加。泪腺上皮细胞是终末分化的,因此被认为不能增殖。我们发现,小鼠泪腺上皮细胞可以增殖,以应对组织的侮辱。本申请的总体目标是解释在实验诱导的炎症后支配小鼠泪腺再生的机制。所获得的知识将揭示促进发炎的人类泪腺再生的新策略,从而恢复足够的房水泪液产生。根据我们的初步数据和文献报道,我们假设实验诱导的泪腺炎症触发腺泡细胞凋亡,随后诱导腺泡细胞从导管细胞或导管细胞相关干/祖细胞分化,随后通过增加成纤维细胞生长因子10(FGF 10)和/或骨形态发生蛋白7(BMP 7)的产生介导增殖。 我们提出了三个具体目标:1 -确定在实验诱导的炎症过程中泪腺上皮细胞是否因凋亡或坏死而丢失; 2-确定哪些细胞负责实验诱导的炎症后小鼠泪腺的再生;和3-确定哪些效应分子负责在实验诱导的炎症后触发泪腺修复,并研究这些因素是否可以触发/加速疾病状态下的泪腺修复。目前还没有治疗由泪腺的产湿细胞损失引起的严重干眼症的方法。这里描述的研究,如果成功,将导致新的策略来阻止,甚至逆转,这些细胞的损失,这将恢复正常的泪液产生,并减轻与干眼症相关的眼表不适。公共卫生相关性目前还没有治疗由泪腺的产湿细胞损失引起的严重干眼症的方法。我们发现,小鼠泪腺上皮细胞可以增殖,以应对组织的侮辱。本申请的总体目标是解释在实验诱导的炎症后支配小鼠泪腺再生的机制。所获得的知识将揭示促进发炎的人类泪腺再生的新策略,从而恢复足够的房水泪液产生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DRISS ZOUKHRI其他文献

DRISS ZOUKHRI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DRISS ZOUKHRI', 18)}}的其他基金

Role of lacrimal gland myoepithelial cells in dry eye disease
泪腺肌上皮细胞在干眼病中的作用
  • 批准号:
    10553199
  • 财政年份:
    2019
  • 资助金额:
    $ 50万
  • 项目类别:
STIMULUS/SECRETION COUPLING IN DISEASED LACRIMAL GLAND
患病泪腺中的刺激/分泌耦合
  • 批准号:
    6138222
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
Stimulus-Secretion Coupling in Diseased Lacrimal Gland
患病泪腺中的刺激-分泌耦合
  • 批准号:
    6936505
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
Stimulus-Secretion Coupling in Diseased Lacrimal Gland
患病泪腺中的刺激-分泌耦合
  • 批准号:
    8585380
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
STIMULUS/SECRETION COUPLING IN DISEASED LACRIMAL GLAND
患病泪腺中的刺激/分泌耦合
  • 批准号:
    6342671
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
Stimulus-Secretion Coupling in Diseased Lacrimal Gland
患病泪腺中的刺激-分泌耦合
  • 批准号:
    6954754
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
Stimulus-Secretion Coupling in Diseased Lacrimal Gland
患病泪腺中的刺激-分泌耦合
  • 批准号:
    6686982
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
Stimulus-Secretion Coupling in Diseased Lacrimal Gland
患病泪腺中的刺激-分泌耦合
  • 批准号:
    8721960
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
STIMULUS/SECRETION COUPLING IN DISEASED LACRIMAL GLAND
患病泪腺中的刺激/分泌耦合
  • 批准号:
    6489847
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:
STIMULUS/SECRETION COUPLING IN DISEASED LACRIMAL GLAND
患病泪腺中的刺激/分泌耦合
  • 批准号:
    2739215
  • 财政年份:
    1999
  • 资助金额:
    $ 50万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 50万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 50万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了